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Abstract
West Nile virus (WNV) is a worldwide distributed mosquito-borne flavivirus that naturally cycles between birds and
mosquitoes, although it can infect multiple vertebrate hosts including horses and humans. This virus is responsible for
recurrent epidemics of febrile illness and encephalitis, and has recently become a global concern. WNV requires to transit
through intracellular acidic compartments at two different steps to complete its infectious cycle. These include fusion
between the viral envelope and the membrane of endosomes during viral entry, and virus maturation in the trans-Golgi
network. In this study, we followed a genetic approach to study the connections between viral components and acidic pH.
A WNV mutant with increased resistance to the acidotropic compound NH4Cl, which blocks organelle acidification and
inhibits WNV infection, was selected. Nucleotide sequencing revealed that this mutant displayed a single amino acid
substitution (Lys 3 to Glu) on the highly basic internal capsid or core (C) protein. The functional role of this replacement was
confirmed by its introduction into a WNV infectious clone. This single amino acid substitution also increased resistance to
other acidification inhibitor (concanamycin A) and induced a reduction of the neurovirulence in mice. Interestingly, a
naturally occurring accompanying mutation found on prM protein abolished the resistant phenotype, supporting the idea
of a genetic crosstalk between the internal C protein and the external glycoproteins of the virion. The findings here reported
unveil a non-previously assessed connection between the C viral protein and the acidic pH necessary for entry and proper
exit of flaviviruses.
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Introduction
West Nile virus (WNV) is a member of the Flaviviridae family that
belongs to the Flavivirus genus. It is classified inside the Japanese
encephalitis serocomplex together with Japanese encephalitis, St.
Louis encephalitis, and Murray Valley encephalitis viruses, among
others. The Flavivirus genus also contains other important
pathogens as Dengue, tick-borne encephalitis, or Yellow fever
viruses [1,2,3]. A wide range of bird species provide the natural
hosts for WNV, and the virus cycles between birds and
ornithophilic mosquitoes that act as its vector. In addition to
birds, WNV also infects multiple vertebrate species including
horses and humans. Clinical manifestations of the infection range
from asymptomatic or febrile illness to a neuroinvasive disease that
can result in fatal encephalitis [4]. WNV has been historically
associated with asymptomatic infections and sporadic disease
outbreaks in humans and horses in Africa, the Mediterranean
basin, the Middle East, and Australia. Nowadays, due to climate
warming, changes in vector feeding behaviour, and spread
through the globalization of trade and travel, this mosquito-borne
flavivirus is worldwide distributed, and has become a global
concern [5,6,7]. Only in the US, about 3 million infections
resulting in about 780,000 illness have been estimated from WNV
introduction in 1999 through 2010 [8]. Currently there is no
vaccine or specific therapy approved for use in humans [9].
The genome of WNV is a single stranded RNA molecule of
positive polarity about 11,000 nucleotides in length [10]. This
molecule encodes a single open reading frame that is translated
into a single polyprotein. The viral polyprotein is cleaved into
three structural proteins –capsid or core (C), pre-membrane/
membrane (prM/M) and envelope (E) proteins– and seven non-
structural proteins [1,2,3]. The genomic RNA is enclosed within a
nucleocapsid composed of multiple copies of the C protein, which
constitutes the core of the virion and is enveloped by a lipid bilayer
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[11]. Mature virions are approximately 50 nm in diameter and
display a smooth outer surface composed of 180 copies of the small
M protein and an equal number of E glycoprotein copies arranged
as 90 anti-parallel homodimers resulting in a particle of pseudo-
icosahedral symmetry [11].
Virions assemble and bud into the endoplasmic reticulum
[12,13] and require trafficking along the secretory pathway for
maturation [13]. During this process, the flavivirus prM protein is
cleaved by a cellular furin-like protease within the acidic
environment of the trans-Golgi network. This orchestrates
profound rearrangements of viral glycoproteins that result in the
acquisition of the mature structure of the virion [14,15,16]. While
this cleavage is a required step in the viral life cycle, it can be
inefficient; suggesting that complete maturation is not required for
infectivity [17,18]. Indeed, the presence of flaviviral ‘mosaic’
particles combining regions of mature and immature structure has
been documented [19], and the degree of maturation of flavivirus
particles has been related to different aspects of their interaction
with antibodies [18,20,21,22]. An acidic pH step is not only
required for viral maturation during WNV infectious cycle, but
also during viral entry [23,24]. The acidic pH inside endosomes
triggers rapid conformational rearrangements on the E glycopro-
tein of internalized virions, leading to the formation of trimers
together with the exposure of the hydrophobic fusion loop of the E
glycoprotein [23,25,26]. These phenomena promote viral mem-
brane fusion and release of the nucleocapsid into the cytosol
[23,24,25,26].
Characterization of viruses with altered pH requirements
provides both structural and mechanistic information regarding
the processes in which acidic pH is involved [27,28,29]. A strategy
to isolate this class of mutants consists on the selection of mutants
resistant to drugs that impair organelle acidification, such as the
weak base ammonium chloride, NH4Cl [27,30,31]. The sensitivity
of WNV to treatment with NH4Cl has been well documented
[16,32,33], and the inhibitory effect of this chemical was related to
two different processes: the inhibition of endosome acidification
during viral entry, hence impairing membrane fusion [32,33]; and
the blockage of furin-mediated cleavage of prM at the trans-Golgi,
thus impeding virus maturation [16,18]. In this study, we have
isolated and characterized a WNV mutant with increased
resistance to the acidotropic agent NH4Cl. In contrast to other
previously described flaviviruses with altered pH requirements,
which exhibited mutations on the proteins that conform the
external shell of the virion (E and M) -[34] and references therein-,
the WNV mutant here reported displayed a single amino acid
substitution on the internal core protein. This amino acid
substitution also increased resistance to other acidification
inhibitor and induced a reduction of the neurovirulence in mice.
The findings here reported unveil a non-previously assessed
connection between the viral C protein and the acidic pH involved
on entry and maturation of flaviviruses.
Methods
Ethics Statement
All animals were handled in strict accordance with the
guidelines of the European Community 86/609/CEE at the
biosafety animal facilities of the Centro de Investigacio´n en
Sanidad Animal of the Instituto Nacional de Investigacio´n Agraria
y Alimentaria (CISA-INIA). The protocols were approved by the
Committee on Ethics of Animal Experimentation of INIA (permit
number 2012-05).
Cells, Virus, Infections, and Virus Titrations
Vero and baby hamster kidney (BHK)-21 cells were grown as
described [35]. Unless specified, all tissue culture reagents were
from Lonza (Verviers, Belgium). The origin and history passage of
WNV NY99-flamingo382–99 strain has been previously described
[10,35,36]. For infections performed in liquid medium, Vero cells
were washed twice with EMEM before addition of the viral
inoculum, and after 1 h at 37uC, the virus was removed and fresh
medium containing 2.5% FBS was added. Viral samples were
titrated on Vero cells by standard plaque assay in semisolid
agarose medium [35]. Viral stocks were produced in the absence
of NH4Cl and titrated also in the absence of the drug unless
specified.
Drug Treatments
Inhibition of organelle acidification was performed with NH4Cl
(Merck) or concanamycin A (Sigma, St Louis, MO) as described
previously [30]. Cells were treated for 1 h prior to infection with
25 mM NH4Cl or 30 min with concanamycin A (10 or 100 nM).
Both drugs were maintained throughout the whole infection time
to avoid cellular recovery. In all experiments involving NH4Cl,
extracellular pH was buffered with 25 mM HEPES at pH 7.5
(Sigma). Inhibition of furin-mediated maturation of WNV was
performed with furin inhibitor I, decanoyl-Arg-Val-Lys-Arg-
chloromethylketone (Calbiochem, Darmstadt, Germany) as re-
ported [21,22]. Cells were treated 30 min prior to infection with
25 mM furin inhibitor I and the drug was maintained throughout
the whole infection time. As the half-life of furin inhibitor I in
aqueous solution is about 4 to 8 h [37], additional furin inhibitor I
was added at 16 h.p.i. to ensure blockage of the progeny virus
maturation [22]. Control cells were treated with the same amount
of drug vehicle (H2O for NH4Cl, and dimethyl sulfoxide, DMSO,
for concanamycin and furin inhibitor I).
Purification of Virions
Supernatants from infected cultures treated or not with NH4Cl
were harvested 24 h.p.i. and cleared from cellular debris by
centrifugation at 8506g for 15 min, followed by centrifugation at
12,0006g for 30 min. Viral particles were concentrated from
cleared supernatants by ultracentrifugation at 141,0006g for 2.5 h
through a 20% sucrose cushion in PBS. The pellets containing
viral particles were resuspended in PBS and analyzed by western
blot.
Immunofluorescence
Immunofluorescence detection of WNV-infected cells was
performed following a previously reported protocol [38]. For this
purpose, monoclonal antibody 3.67G (Millipore, Temecula, CA)
directed against the E glycoprotein of WNV was used in
combination with appropriated secondary antibodies labelled with
Alexa Fluor 488 (Molecular Probes, Eugene, O).
Western Blot
WNV glycoproteins from concentrated virions were detected by
western blot using monoclonal antibody 3.67G to detect E
glycoprotein, or a rabbit polyclonal antibody against the M protein
(Imgenex, San Diego, CA), as previously described [38]. Proteins
were detected by chemiluminiscence using a ChemiDocTM XRS+
System (Bio-Rad, Hercules, CA). The intensity of protein bands
was quantified with ImageLabTM 2.0.1 software (Bio-Rad).
NH4Cl-resistant WNV
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In vitro Furin Treatment of Immature Viral Particles
Treatment with furin was performed following a previously
described procedure with minor modifications [14,39]. Briefly,
WT and Res virus were purified as described above and
dialyzed against PBS to remove the remaining sucrose. Viral
samples were mixed with the same amount of 50 mM 4-
morpholineethanesulfonic acid, MES (Sigma). Samples were
treated or not (control) with furin (New England Biolabs,
Ipswich, MA) at 30uC for 16 h in the presence of 3 mM CaCl2
and then neutralized with a buffer containing 100 mM Tris at
pH 8.0 and 120 mM NaCl. The infectivity in each sample was
determined by standard plaque assay in semisolid agarose
medium [35]. The number of PFU developed for each virus
subjected to furin treatment was counted and expressed as the
percentage of infectivity compared to that obtained in untreated
samples (considered as 100% of infectivity).
Acid Sensitivity Assays
WNV acid sensitivity was determined by a modification of the
previously described procedure [31,35]. Aliquots containing about
107 PFU of each virus tested were treated with different amounts
of 1 MMES to give a final pH of 7, 6,5 or 6 and incubated 15 min
at 37uC. Then, samples were neutralized with the appropriate
amount of 5 M NaOH. The pH of the samples was verified after
acidification and also after neutralization. Samples prepared in this
way were serially diluted and added to Vero cells grown on 96-well
plates as for standard TCID50 assays. Cells were fixed with 4%
formaldehyde and stained with crystal violet one week p.i. [35].
The remaining infectivity in each sample treated with acidic pH
was calculated as the reciprocal of the last virus dilution that
induced cytophatic effect and expressed as the percentage of
infectivity relative to the infectivity in control samples (pH 7,
100% infectivity).
Analysis of the Genetic Stability of the Mutants
Viruses were subjected to ten serial passages on Vero cells in
the absence of NH4Cl and sequenced by automatic DNA
sequencing (Macrogen Inc., Seoul, Korea) [35]. Biological
clones of each virus that had been serially passaged 10 times
in the absence of NH4Cl were plaque purified and directly
sequenced. Sequences were confirmed by at least two indepen-
dent sequence reactions.
Viral RNA Extraction, cDNA Synthesis, and DNA
Sequencing
Viral RNA was extracted from the supernatants of infected
cultures, or from homogenate brain extracts from infected mice
[36,40] using a NucleoSpin Viral RNA Isolation kit (Macherey-
Nagel GmbH & Co., Du¨ren, Germany). cDNA was synthesized
by reverse transcription of viral RNA using SuperScriptTM One-
Step RT-PCR with PlatinumH Taq (Invitrogen) and the
appropriate oligonucleotide primers (sequences provided upon
request). The size and purity of the amplified PCR products
were checked by agarose gel electrophoresis and ethidium
bromide staining. PCR products were purified using a
Speedtools PCR Clean-up kit (Biotools B&M Labs S.A.,
Madrid, Spain), quantified by UV spectrophotometry using
Nanodrop equipment (NanoDrop Tecnologies, Wilmington, DE)
and sequenced as described above. Nucleotide positions
correspond to those described previously for WNV strain
NY99-flamingo 382–99 [10].
Quantitative RT-PCR
Viral RNA was extracted as described above, and the amount of
viral RNA copies was determined by quantitative RT-PCR [41] as
genomic equivalents to PFU/ml by comparison with RNA
extracted from previously titrated samples [36,40].
Infectious Clone Manipulation, in vitro Transcription of
Viral RNA, and Transfection of Eukaryotic Cells
Plasmid pFLWNV [42], which contains the full length cDNA
of WNV strain NY99, was used to construct plasmid pFLWNV-
A103G bearing the nucleotide substitution found in the NH4Cl-
resistant WNV reported here. To this end, the DNA fragment
(3652 base pairs) encompassed between BamHI and SphI
restriction sites of pFLWNV was synthesized in vitro containing
the nucleotide replacement A103G on the cDNA of WNV by
GenScript (Piscataway, NJ). This DNA was cloned between the
same restriction sites of CopyControlTM pCC1BACTM plasmid,
and amplified using TransforMaxTM EPI300TM E. coli compe-
tent cells (Epicentre Biotechnologies, Madison, WI). The
plasmid was digested using the same restriction endonucleases
(Roche, Manheim, Germany) and the insert bearing WNV
nucleotide substitution A103G was ligated into pFLWNV
digested with the same enzymes using T4 DNA ligase (Roche).
ElectroMAXTM DH5a-ETM competent E. coli cells (Invitrogen)
were transformed with infectious cDNA clones by electropora-
tion using a GenePulser apparatus (Bio-Rad). Nucleotide
sequences of plasmids pFLWNV and pFLWNV-A103G were
verified by nucleotide sequencing.
Plasmid DNA from infectious clones was purified from bacteria
through PureLinkTM HiPure Plasmid Filter Maxiprep kit (Invitro-
gen) and linearized by digestion with XbaI (Roche). Viral RNA was
synthesized by in vitro transcription using the mMESSAGE
mMACHINEH kit (Ambion, Austin, TX) as previously described
[42]. Viral RNA was transfected into BHK-21 cells using
LipofectinH Transfection Reagent (Invitrogen) as indicated by
the manufacturer. Three days post-transfection, the recovered
viruses were harvested and titrated on Vero cells. The identity of
viral RNA extracted from recovered viruses was also confirmed by
nucleotide sequencing.
Mice Experiments
Mouse experimentation was carried out in our BSL-3
containment facilities. Groups of eight-week-old Swiss female
mice were intraperitoneally (i.p.) infected with 102, 104 or 107
PFU/mouse of each virus analyzed resuspended in 100 ml of
PBS. Mice were kept with ad libitum access to food and water
during the experiment and were monitored daily for signs of
illness up to 15 days p.i. Those mice showing clear signs of
disease, as ruffled fur, hunching, hind limb weakness, and
paralysis, were anesthetized and sacrificed, as were all surviving
mice at the end of the experiments.
Data Analysis
To test the significance of the differences, analysis of the
variance (ANOVA) was performed with statistical package SPSS
15 (SPSS Inc, Chicago IL), applying Bonferroni’s correction for
multiple comparisons. Data are presented as mean 6 standard
deviation (SD). Asterisks (*) in the figures denote statistically
significant differences (P,0.05). Kaplan-Meier survival curves
were analyzed by a logrank test using the statistical package
GraphPad PRISM v.2.01 (GraphPad Software). The median
survival time (MST) was calculated for every group of inoculated
mice.
NH4Cl-resistant WNV
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Results
Selection of a WNV Population with Increased Resistance
to NH4Cl
WNV with increased resistance to NH4Cl was selected from a
cell culture passaged WNV strain [36] responsible for the outbreak
of encephalitis in NY in 1999 (NY99) [10], here termed WT. To
this end, WNV virus was propagated on Vero cells in the presence
of 25 mM NH4Cl, until cytophatic effect was clearly visible, about
3 days postinfection (p.i.). At this time point, the virus progeny was
harvested and used to infect fresh Vero cells in the presence of
NH4Cl. Serial infections were repeated 10 times in the presence or
in the absence of the drug (control conditions). Viruses from
passage 10 were amplified by a subsequent round of infection in
absence of NH4Cl and used in further experiments, thus
preventing possible bias derived from the production of immature
particles due to NH4Cl treatment.
The degree of resistance to NH4Cl was assayed on these viral
populations by plaque assay performed in the presence or in the
absence of NH4Cl (Fig. 1A). In the presence of NH4Cl, the
diameter of the lysis plaques developed by the WT virus at 3 days
p.i. (1.1060.27 mm) was smaller (44% reduction, P,0.001) than
that produced by the population passaged 10 times in the presence
of NH4Cl (1.9760.53 mm), hence named Res (abbreviation of
Resistant) WNV. However, both viruses displayed similar plaque
sizes (WT, 3.3460.76 mm; Res, 3.3360.80) in absence of NH4Cl.
To rule out that this difference between WT and Res WNVs was
derived from tissue culture adaptation upon serial passages, a
population of WNV WT passaged 10 times in absence of NH4Cl
(termed WTp10) was included in the analysis. This viral
population showed no increase in plaque size compared to that
of WT when plated in the presence of NH4Cl (0.9860.29 mm),
supporting the specificity of the increase in plaque size noted in the
NH4Cl Res population. The sensitivity to NH4Cl of Res
population was further analyzed by immunofluorescence staining
of infected cells (Fig. 1B). No significant differences were noted
between cells infected with WT or Res WNVs when infections
were performed in the absence of NH4Cl, but in cells treated with
NH4Cl, a statistically significant reduction (about 80%, P,0.001)
of the percentage of infected cells was observed for WT virus when
compared to Res WNV.
As acidic pH is a key for distinct steps of the flavivirus infectious
cycle (see Introduction), alterations responsible for the increase in
NH4Cl resistance of Res virus could carry a reduction of viral
fitness. To test this hypothesis, the growth kinetics of both WT and
Res WNVs were compared by titration of viruses released to the
extracellular medium at 37 or 40uC (Fig. 1 C and D). Both viruses
shared similar growth curves at the two temperatures analyzed.
However, when time course analysis of the virus released to the
extracellular medium was analyzed in the presence of NH4Cl, an
increase of about one order of magnitude was noticed for Res virus
during the first 24 h of infection (Fig. 1E), confirming the partial
resistance to NH4Cl of Res population. Overall, these results
indicate that Res population has an increase in the resistance to
NH4Cl treatment which carries no major alterations of viral fitness
under normal culture conditions.
Resistance to NH4Cl also Confers Resistance to Other
Inhibitor of Acidification
The sensitivity to NH4Cl of Res virus was compared to that of
WT by performing infections in liquid medium and determining
the virus yield at 24 h.p.i. (Fig. 2A). WT and Res WNVs displayed
dose-response behaviour against increasing concentrations of
NH4Cl. Virus yield of Res WNV was about one order of
magnitude higher than that of WT in cultures treated with either
10 or 25 mM NH4Cl, confirming the selective advantage of this
population against treatment with NH4Cl.
Since the effect of NH4Cl treatment is the inhibition of
acidification, the effect of concanamycin A, another inhibitor of
acidification [43], on the infection WT and Res WNVs was also
analyzed (Fig. 2B). Treatment with concanamycin A resulted in a
decrease of virus yield of both viruses, although virus yield of Res
WNV was again about one order of magnitude higher than that of
WT virus in cells treated with either 10 or 100 nM concanamycin
A. This indicates that resistance to inhibition of acidification
induced by treatment with NH4Cl also confers resistance to
another drug as concanamycin A, suggesting that the viral
mechanism of resistance to acidification inhibitors is common
for both inhibitors.
Acidic pH has been related to furin-mediated cleavage of
flavivirus prM during virus maturation, and also related to viral
particle infectivity (see Introduction). Along this way, we studied if
the mechanism of resistance to inhibition of organelle acidification
also conferred resistance to inhibition of furin-mediated matura-
tion of viral particles. To this end, the effect of furin inhibitor I
(decanoyl-Arg-Val-Lys-Arg-chloromethylketone), which has been
reported to specifically inhibit this cleavage in WNV and other
flaviviruses as Dengue virus [21,22], was assayed on the infection
of WT and Res WNVs (Fig. 2C). A similar reduction of the virus
titer (compared to untreated cells) of both WT and Res WNVs was
observed, thus showing that infection with Res virus was not
resistant to inhibition of furin-mediated maturation of viral
particles. To further study possible alterations on maturation,
the degree of maturation of WT and Res viral particles was also
investigated (Fig. 2D). Viral particles produced in the presence or
in the absence of NH4Cl were concentrated by ultracentrifugation
and the amount of mature M protein was analyzed by western
blot. These experiments showed that viral particles produced in
the presence or in the absence of NH4Cl of WT and Res WNVs
displayed a similar reduction in the amount of mature M protein,
suggesting that furin-mediated cleavage of prM was impaired by
NH4Cl for both WT and Res virus.
The furin cleavage site in prM is only exposed when the virus
has undergone maturation [14,39]. In this way, treatment of
flavivirus immature particles with furin at acidic pH increases the
infectivity of these particles by induction of the pH-induced
rearrangements that allow furin-mediated cleavage of prM [39].
To test the accessibility of furin cleavage site at neutral and low
pH, both WT and Res virus produced in the presence of NH4Cl
(to prevent acid-induced rearrangements and furin cleavage at the
trans-Golgi) were treated or not with furin at neutral or acidic pH
and the infectivity in each sample was determined (Fig. 2E and F).
No significant increase in virus infectivity was observed for WT or
Res virus treated with furin at neutral pH, when compared to
untreated samples (Fig. 2E). However a significant increase in the
infectivity of viral samples treated with furin at acid pH was
noticed, and the extent of this increase was similar for WT and
Res virus (Fig. 2F). This suggests that the structural change
necessary to expose the furin cleavage site in Res virus requires
acidic pH, as observed for WT. Overall, these results confirm that
the mechanism of resistance to inhibition of acidification of Res
WNV is not related to alterations in viral particle maturation.
Relationship between Viral Genome Copies and
Infectivity
The production of viral RNA in infected cultures treated with
NH4Cl, concanamycin A or furin inhibitor I was analyzed by
quantitative RT-PCR and determined as genomic equivalent to
NH4Cl-resistant WNV
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PFU/ml by comparison with previously titrated samples. These
values were compared to the content on infectious particles (PFU/
ml), and the PFU/genomic equivalent ratio was calculated as an
indicator of the specific infectivity per viral genome (Table 1). Res
WNV displayed an increase of about one order of magnitude in
the ratio PFU/genomic equivalent when compared to WT virus
upon NH4Cl, or concanamycin A, treatment. However, similar
PFU/genomic equivalent ratio was obtained for both WT and Res
viruses in control cells or in those treated with furin inhibitor I
(Table 1). In this way, WT and Res WNVs produced similar
amounts of infectious particles when furin-mediated maturation
was impaired (cells treated with furin inhibitor I), but Res virus
produced about ten-fold more infectious particles than WT upon
treatment with inhibitors of acidification.
Acid-inactivation Analyses
As commented in the Introduction, WNV fusion is triggered by
acidic pH inside endosomes. According to this mechanism, the
exposure of WNV to acid media in the absence of target
membranes results in E protein rearrangement, premature
exposure of the fusion loop, and rapid and irreversible inactivation
of fusion competence causing a loss of infectivity [32,44]. Analysis
of the acid-induced inactivation of both WT and Res virus showed
that, in the case of viruses produced in the absence of NH4Cl,
which mainly consist on mature viral particles, no significant
differences were found between WT and Res virus (Fig. 3A).
Similar assays were also performed using viral preparations
produced in the presence of NH4Cl (immature particles)
(Fig. 3B). While no significant differences were observed between
both viruses at pHs 7 or 6.5, the infectivity of Res virus produced
in the presence of NH4Cl was significantly reduced at pH 6 when
compared to that of WT virus produced in the same conditions,
and also evidenced that WT virus grown on NH4Cl was not
significantly inactivated upon exposure to acidic pH across the pH
range analyzed. These results point that mature particles of Res
virus do not display major alterations of fusion pH threshold when
compared to WT virus, whereas Res particles produced in the
presence of NH4Cl can be inactivated by acidic pH in a similar
way than those produced in the absence of NH4Cl (in contrast to
WT virus). Overall these experiments suggest that Res WNV is
able to produce more fusion-competent particles (infectious
particles) in the presence of NH4Cl than WT.
Genetic Determinants of the Resistance to NH4Cl
The genetic basis of resistance to inhibitors of acidification was
analyzed in the Res WNV. The complete genomic sequences of
the parental WT and Res populations were determined and
compared (Table 2). Seven synonymous changes (T4107C,
A5280G, T7015C, C8235T, T8811C, T10338C and A10851G)
were found in the consensus sequence of both viruses when
compared with the reference parental sequence WNV strain
NY99-flamingo 382–99 (GenBank accession no. AF196835.2)
[10]. The presence of these silent replacements has been
previously reported for the WT population, as a probable reflect
of the passage history of the virus [35]. In addition, a single non-
synonymous nucleotide change was found imposed in the Res
population. This non-synonymous replacement, the transition
A103G, was responsible for the amino acid replacement K3E in
the C protein. Two additional positions in the Res population
displayed non-synonymous transitions (G7183A and A7184G),
located on the coding region of NS4B protein, although these
substitutions were not dominant in the population. The selection
of A103G nucleotide substitution was traced along passage history
of Res population. This nucleotide substitution appeared at a
detectable level at passage 4 and increased with passage number.
Selection of this nucleotide substitution was not observed for the
viral population that was propagated in absence of NH4Cl (data
not shown). Eight biological clones were isolated from Res
population by amplification of individual lysis plaques and the
virus yield produced by these clones in the presence of NH4Cl was
analyzed. Mean virus titer of the clones (six) that carried
nucleotide substitution A103G was significantly higher
(P,0.021) than those of the clones (two) with WT nucleotide at
this position (Fig. 4). Taken together, these results support that the
nucleotide replacement A103G, which introduces amino acid
replacement K3E in the WNV C protein, is responsible for the
increase of resistance to treatment with NH4Cl exhibited by Res
WNV.
The Single Amino Acid Substitution K3E in the WNV C
Protein is Sufficient to Increase Resistance to Inhibition of
Acidification
The role of nucleotide substitution A103G was further
evaluated by introducing this replacement into the infectious
clone pFLWNV, which contains the full length cDNA of the
WNV strain used in this study [42]. Viral RNA was synthesized
from both infectious cDNA clones by in vitro transcription and
transfected into BHK-21 cells. The resistance to NH4Cl of viruses
recovered from infectious clones was first analyzed by plaque assay
performed in the presence or in the absence of NH4Cl (Figs. 5A
and B). Both viruses displayed similar plaque size (WT,
3.2160.59 mm; A103G, 3.1260.60) in the absence of NH4Cl.
However, when plated in the presence of NH4Cl, the diameter of
lysis plaques developed by the WT virus was smaller
(0.6860.29 mm, 47.3% reduction, P,0.001) than that produced
by the A103G virus in the presence of NH4Cl (1.2860.43 mm).
The sensitivity to NH4Cl of A103G virus was compared to that of
WT by performing infections in liquid medium (Fig. 5C).
Although both viruses grew at a similar level in the absence of
the drug, virus yield of A103G virus was about one order of
magnitude higher than that of WT virus in cultures treated with
either 10 or 25 mM NH4Cl, confirming that the introduction of
this mutation into WNV increased resistance to NH4Cl. The
sensitivity to concanamycin A was also lower for A103G virus
(Fig. 5D). The degree of resistance of A103G virus was similar to
that of Res virus (Fig. 5E), thus confirming that the single amino
Figure 1. Isolation and growth properties of a WNV population with increased resistance to NH4Cl. (A) Lysis plaques produced by
different populations of WNV in the absence (Control) or in the presence of 25 mM NH4Cl. WT corresponds to WNV NY99. WTp10 correspond to a
population of WNV WT selected after 10 passages without NH4Cl. Res corresponds to a population of WNV WT selected after 10 passages in the
presence of NH4Cl. Lysis plaques were visualized by staining of Vero cells with crystal violet 3 days p.i. (B) Vero cells treated or not with 25 mM NH4Cl
were infected with WT or Res WNV (MOI of 0.01 PFU/cell). The percentage of infected cells (positively stained with an antibody against the E
glycoprotein) was determined by immunofluorescence and confocal microscopy at 48 h.p.i. (C) Time-course analysis of infectious progeny release by
cells infected with WT or Res WNVs. Vero cells were infected (MOI of 0.5 PFU/cell) at 37uC and the virus progeny released to the medium was
determined by plaque assay at different times p.i. (D) Cells infected as in (C) were incubated at 40uC and the viral titers in the supernatants were
determined as described [35]. (E) Cells infected as in (C) were incubated at 37uC in the presence of 25 mM NH4Cl, and the viral titer in supernatant
was determined. Error bars represent SD. The data presented are product of three independent experiments.
doi:10.1371/journal.pone.0069479.g001
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acid substitution K3E in the WNV C protein, derived from
introduction of the nucleotide substitution A103G, is sufficient to
increase resistance to inhibitors of acidification and completely
responsible of the phenotype of Res virus.
Comparative Genomics of WNV C Protein
The amino acid substitution K3E found on Res WNV, located
on the N–terminus of C protein -which is presumed to be a
disordered region (Fig. S1A and [45])- involves replacement of a
basic residue for a negatively charged one. The WNV C protein is
a highly basic protein containing 26 basic residues (K or R), and
only 3 acid residues, D or E (Fig. 6A). This prompted us to analyze
if this type of charge replacement amino acid substitution was
frequent by comparing 486 sequences of the WNV C protein from
isolates that varied geographically and temporally and are
available at GenBank. The criterion for inclusion in the analysis
was that the deposited sequence covered at least 98% of the C
protein. Sequence variability was similar along the C protein,
except for a highly variable region located at the hydrophobic C-
terminus, after the maturation cleavage site (Fig. 6B and S1B).
Comparison of amino acid sequences revealed that the K3 was
invariant in 99.38% of sequences analyzed (Fig. 6B). The
remaining 0.62% of the analyzed sequences (3 sequences)
corresponded to isolates of the genetically divergent Rabensburg
lineage that carried other basic residue (R) in this position
(ADG36441.1, ADG36442.1, and AAW81711.1). This analysis
highlights the importance of the conservation of a positive amino
acid residue in this location. Even more, given the 26 basic
residues of WNV C protein, 16 were found to be invariant, 6
tolerated permutation for other basic residue, only 1 was replaced
by an acid residue (K10D in ADG36441.1, ADG36442.1, and
AAW81711.1), and 3 tolerated variation to other non-basic, non-
acid residues (Fig. 6C). These analyses also revealed that
substitutions leading to the introduction of negatively charged
residues were very infrequent. Within the sequences analysed, only
6 (1.2%) showed this kind of variations: G7E (ADK62441.1), G9D
(ADK62428.1), and the previously mentioned K10D from
Rabensburg lineage (ADG36441.1, ADG36442.1,
AAW81711.1). Considering the potential relevance of the
presence of basic residues on the N-terminus of the flaviviral C
proteins, the analysis was also extended to the C protein of other
flaviviruses, unveiling that K3 together with K4 were conserved
among several flaviviruses of the Japanese Encephalitis serocom-
plex, and that other members of the flavivirus genus (i.e. Dengue
and Yellow Fever viruses) also presented accumulation of basic
residues at the N-terminus of the protein (Fig. S2). Overall, these
findings reinforce the functional importance of positively charged
amino acids on the N-terminus of the WNV C protein.
NH4Cl-resistant WNV Displays Reduced Virulence in vivo
The in vivo infectivity of NH4Cl-resistant viruses was analyzed
using a murine infection model for WNV. Mice were i.p. infected
with different doses (102, 104, or 107 PFU/mouse) of WT, Res and
A103G viruses and the mortality was recorded along time (Fig. 7A,
B and C). Animals inoculated with Res or A103G viruses
displayed a significant reduction of the mortality when compared
to the WT at the three doses assayed, whereas the mortality
induced by Res and A103G was not significantly different. Median
survival times (MSTs) for mice inoculated with WT virus ranged
from 10 (107 PFU/mice) to 11 days (102 PFU/mice), while those
of mutant viruses were .15 days. A lack of dose response in the
survival rates for animals infected with WT or A103G virus was
noticed, and survival curves of animals infected with Res mutant
also displayed a weak dose-response. This is compatible with
previous observations of a lack of a direct relationship between
WNV infecting dose and mortality rates reported by us and others
[36,46,47,48]. As none of the doses assayed for Res or A103G
virus killed at least 50% of the animals, the exact determination of
50% lethal dose (LD50) for mutant viruses was impaired. Albeit
from these results, it could be extrapolated that LD50 of A103G
Figure 2. Resistance to NH4Cl also increases the resistance to other inhibitor of acidification. Vero cells treated with NH4Cl (A),
concanamycin A (B) or furin inhibitor I (C) were infected with WT or Res WNVs (MOI of 0.5 PFU/cell). Virus yield was determined by plaque assay at
24 h.p.i. as described [35]. (D) Cells treated or not with NH4Cl were infected with WT or Res WNVs. Viral particles released to the infectious medium
were concentrated by ultracentrifugation through a 20% sucrose cushion. The content of the E and M proteins was determined by western blot as
described in Material and Methods. The graph displays the M content relative to the E content in each sample. AU, arbitrary units. (E and F) Effect of
in vitro furin treatment on the infectivity of WT and Res virus. WT or Res virus grown in the presence of NH4Cl was purified and treated in vitro with
recombinant furin at neutral (E) or acid pH (F). See Methods for details. The remaining infectivity in each sample was determined by standard plaque
assay and expressed as percentage of infectivity compared to each control sample untreated with furin (considered as 100% of infectivity). Error bars
represent SD. The data presented are product of three independent experiments.
doi:10.1371/journal.pone.0069479.g002
Table 1. Relationship between infectivity and genomic RNA copies.
Virus Treatment
Control NH4Cl Concanamycin A Furin inhibitor I
Infectivity (PFU/ml) WT 9.7610761.36107 2.9610561.06104 9.7610261.26102 3.2610662.96104
Res 2.1610865.26107 1.5610764.86106 2.5610469.16103 1.8610663.16105
RNA copies (Genomic equivalent to PFU/ml)d WT 1.0610864.26107 8.9610664.26104 6.3610665.96105 1.8610864.76107
Res 1.7610863.36107 3.1610768.06106 1.9610765.76106 1.2610864.26107
Infectivity/RNA copies (PFU/genomic equvalent) WT 1.060.5 0.03360.0008 0.0001560.0002 0.1860.01
Res 1.360.2 0.4760.3 0.001360.003 0.1560.05
Data are sumarized as mean 6 SD (3 to 6 determinations). Drug treatments used: 10 mM NH4Cl, 10 nM Concanamycin A, or 25 mM furin inhibitor. Control indicates that
no drug was added to the culture medium. The PFUs in the sample were determined by standard titration [35] at 24 h.p.i. The amount of genomic RNA copies was
measured by quantitative RT-PCR (24 h. p.i.) using previously titrated samples, and expressed as genomic equivalents to PFU/ml [40,41].
doi:10.1371/journal.pone.0069479.t001
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Figure 3. Acid inactivation analysis of the WNV population with increased resistance to NH4Cl. Acid-inactivation was analyzed on viruses
produced in the absence (A) or in the presence of NH4Cl (B). Equal titers of the WT and Res viruses were incubated at different pHs, neutralized and
plated as described in Material and Methods. Infectivity was calculated as the percentage of PFU recovered in relation to that obtained at pH 7. Error
bars represent SD. The data presented are product of two independent experiments.
doi:10.1371/journal.pone.0069479.g003
Table 2. Nucleotide substitutions found in the population of
the WNV resistant to NH4Cl.


















39 NCR A10851G A10851G
Nucleotide replacements found on the genomic sequence of WT and Res WNVs
were compared to WNV strain NY99-flamingo 382–99 (GenBank accession no.
AF196835.2) [10]. Amino acid replacements are shown in bold within
parentheses. Mixture indicates that this substitution could be detected on the
chromatogram although it was not dominant in the population.
doi:10.1371/journal.pone.0069479.t002
Figure 4. Nucleotide replacement A103G enhances production
of infectious particles in the presence of NH4Cl. Different
biological clones were isolated from Res population and used to infect
Vero cells in the presence of NH4Cl (MOI of 0.5 PFU/cell). Virus titers
were determined 24 h.p.i. as described [35]. The nucleotide at position
103 is indicated for each individual clone. Dashed white line indicates
the virus titer shown by biological clones bearing the same nucleotide
at this position (A103) than the WT. Error bars represent SD. The data
presented are product of three independent experiments.
doi:10.1371/journal.pone.0069479.g004
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and Res virus was .107 PFU/mice, whereas LD50 of WT virus
was ,102 PFU/mice (Fig. 7A), thus showing a difference of more
than 5 orders of magnitude between WT and NH4Cl-resistant
viruses.
Genetic Stability of Nucleotide Substitution A103G
To analyze the stability of the selected mutation in the absence
of NH4Cl, Res or A103G viruses were subjected to ten serial
passages in the absence of NH4Cl and the identity of the genomic
region encoding the structural proteins (C, prM/M and E) was
determined by nucleotide sequencing (Table 3). The nucleotide
substitution A103G was found in the population after 10 serial
passages in three out of three experiments performed for Res virus,
and similar results were obtained for A103G virus. No additional
nucleotide substitution was noticed, except for the silent nucleotide
replacement G813A, located in the genomic region that encodes
M protein, fixed during the second experiment performed with
A103G virus. The frequency of viruses bearing nucleotide
substitution A103G in the population was also investigated by
analysis of biological clones selected from the population of either
Res or A103G viruses obtained after ten passages in the absence of
NH4Cl (Table 3). All biological clones analyzed carried the
nucleotide substitution A103G, except for one experiment
performed with Res virus in which 2 clones out of 9 analyzed
exhibited a direct reversion to WT. Overall these results indicated
that, nucleotide substitution A103G remained dominant in the
population after 10 serial passages, although the generation of
revertants can be also noticed.
When the genetic stability of nucleotide substitution A103G was
analyzed in vivo (Table 4), the presence of the nucleotide
substitution was observed in the virus recovered from the brain
of 2 out of the 4 dead mice analyzed (mice N.4.2, N.4.3). One of
these mice (N.4.3) also displayed the accumulation of an additional
nucleotide substitution responsible for amino acid replacement
N15S in the prM protein. Interestingly, amino acid replacement
N15S was located on the surface of the pr peptide (Fig. 8A) and
involved a residue that constitutes a conserved N-linked glycosyl-
ation site [49]. Since the introduced S residue can also constitute a
potential O-linked glycosylation site, this possibility was explored
using NetOGlyc predictor server (http://www.cbs.dtu.dk/
services/NetOGlyc/). However no significant O-linked glycosyl-
ation probability was found at this position for mutant pr,
suggesting that N15S abolishes glycosylation at this position
instead of altering the glycosylation pattern. The analysis of
Figure 5. The nucleotide replacement A103G is sufficient to increase resistance to inhibitors of acidification. (A) Lysis plaques
produced by WT and A103G WNVs recovered from infectious cDNA clones pFLWNV and pFLWNV-A103G, respectively. Viruses were plated in the
absence (Control) or in the presence of 25 mM NH4Cl and lysis plaques were visualized by staining of Vero cells with crystal violet 3 days p.i. (B)
Quantitative analysis of the lysis plaque size produced by the different populations of WNV in (A). Vero cells treated with NH4Cl (C) or concanamycin
A (D) were infected (MOI of 0.5 PFU/cell) with WT or A103G viruses recovered from the infectious clones described in (A) and the virus titers were
determined by plaque assay at 24 h.p.i. as described [35]. (E) Comparison of the degree of resistance between A103G and Res virus. The resistance
against inhibition of organelle acidification exerted by NH4Cl or Concanamycin A was calculated as the increase in virus yield compared to the virus
yield displayed by WT viruses under each condition. Error bars represent SD. The data presented are product of three independent experiments.
doi:10.1371/journal.pone.0069479.g005
Figure 6. Comparative genomics analysis of the WNV C protein. (A) Distribution of basic (K and R) and acid (D and E) residues along the WNV
C protein from strain NY99-flamingo 382–99. (B) Analysis of the variability of amino acids inside the WNV C protein. A total of 486 sequences from
isolates that varied geographically and temporally that are available at GenBank were compared, and the percentage of sequences showing amino
acid variation was analyzed for each position. (C) Analysis of the amino acid variation of basic residues of the WNV C protein. White arrow points to
the position mutated that increased resistance to NH4Cl. Black arrowhead indicates the site of maturation cleavage [64].
doi:10.1371/journal.pone.0069479.g006
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nucleotide sequences also revealed the appearance of a reversion
to WT position in mice N.2.1, although this revertant had also
selected two additional nucleotide substitutions responsible for
amino acid replacements Q256L and L355M in the E glycopro-
tein. Both amino acid substitutions were located at the interfaz
between domain I (DI) and DIII of the protein, (Figure 8A and B).
These mutations were close to the single polypeptide linker that
connects DIII with DI and could alter the major positional
rearrangements in which participates this region during the virus
life cycle [23,25]. In addition to these viruses carrying mutations in
the glycoproteins that constitute the external shell of the virion, the
virus recovered from mice N.4.1 also displayed a reversion to WT
position and selection of an additional amino acid replacement
(I38L) in the C protein (Table 4) that was located at the end of a1
helix of C protein (Fig. 8C). Taken together, these results
evidenced that reversion to WT phenotype or selection of
additional nucleotide substitution were common among dead
mice infected with Res virus, pointing to the fact that deleterious
effect of nucleotide substitution, such as the A103G noticed in vivo
(Fig. 7), can be compensated by the selection of viruses carrying
amino acid substitutions in the structural proteins.
A Mutation Located on the prM Protein Abolishes the
Advantage Conferred by K3E Amino Acid Replacement of
Res Virus
The resistance to NH4Cl of the viruses recovered from dead
mice was tested for those viruses bearing additional amino acid
substitutions (N.2.1, N.4.1 and N.4.3). To this end, cells were
infected in the absence (control) or in the presence of NH4Cl and
virus yield was determined by plaque assay (Fig. 9). All viruses
analyzed reached similar virus titers in the absence of NH4Cl,
indicating that these mutations did not confer major disadvantages
under standard infections in tissue cultured cells. On the other
hand, when NH4Cl was added to the infection medium, Res virus
produced the higher virus yield, about one order of magnitude
higher than that of WT, N.4.1 or N.4.3. In the case of N.2.1 virus,
the inhibition exerted by NH4Cl was higher than for Res virus but
not as marked as for WT, N.4.1 and N.4.3 viruses, thus displaying
an intermediate phenotype. These results evidenced that revertant
viruses N.2.1 and N.4.1 that had lost the amino acid replacement
K3E at C protein found in Res virus, suffered from a reduction in
their degree of resistance to NH4Cl. Interestingly, the virus N.4.3,
which carried the additional substitution N15S on prM protein
and that retained K3E amino acid replacement on C protein, grew
at similar levels than WT in the presence of NH4Cl. This strongly
suggests that mutation N15S found in the prM protein of this virus
exhibited a compensatory activity that abolished the advantage
conferred by K3E amino acid replacement on the C protein of Res
virus under impaired organelle acidification.
Discussion
In this report, the isolation and characterization of a WNV
mutant with increased resistance to the acidotropic compound
NH4Cl has been described. NH4Cl acts through ammonia
diffusing into the cell [50]. At neutral pH, weak-base amines are
uncharged and can diffuse across cellular membranes if they are
sufficiently lipophylic. When diffused into acidic membrane
compartments within cells, they become protonated. In their
protonated form, the amines are less lipophylic and consequently
they accumulate within acidified compartments and, thereby, raise
the internal pH [50]. On the contrary, other inhibitors of
acidification, as concanamycin A, block the function of the
vacuolar ATPases, the enzymes that pump protons inside acidic
organelles [43]. The WNV variant here selected displayed
increased resistance to both inhibitors of acidification, showing
that the viral mechanism to escape from inhibition of acidification
exerted by NH4Cl was also valid to escape from concanamycin A.
This indicates that the mutant was resistant to inhibition of
acidification regardless of the method used to achieve it.
When the molecular basis of the increase in resistance to
acidotropic compounds was addressed, it was shown that the
resistant virus carried a single amino acid substitution (K3E) on the
C protein. The nucleotide substitution (A103G) responsible for this
amino acid replacement was introduced into an infectious clone
and the phenotype was reproduced, thus confirming that this
Figure 7. Mice survival after inoculation with NH4Cl-resistant WNV. Groups of eight-weeks old mice were i.p. infected with 10
2 (A), 104 (B),
or 107 (C) PFU/mouse of WT, Res, and A103G WNVs, and monitored daily for 15 days. WT and Res virus correspond to data pooled of three
independent experiments with similar results (32 to 44 animals per dose). Values of A103G virus correspond to a single experiment (12 animals per
dose). The P values for specific comparisons of mortality are shown.
doi:10.1371/journal.pone.0069479.g007
Table 3. Genetic stability of A103G nucleotide substitution after ten serial passages in the absence of NH4Cl.
Experiment
Nucleotide substitutions found in the sequence of genomic
region encoding WNV structural proteins
Proportion of biological clones bearing
nucleotide substitution A103G
Res 1 A103G (K3E) 8/8 (100%)
2 A103G (K3E) 7/9 (77.8%)
3 A103G (K3E) N.D.
A103G 1 A103G (K3E) 8/8 (100%)
2 A103G (K3E), G813A 8/8 (100%)
3 A103G (K3E) N.D.
Mutant WNVs (Res population or A103G virus recovered from infectious clone pFLWNV-A103G) were subjected to 10 serial passages on Vero cells. Viral RNA was
extracted and amplified by RT-PCR and the nucleotide sequence of the genomic region encoding the structural proteins was determined. Nucleotide replacements
found on the genomic sequence of either Res or A103G subjected to 10 serial passages in the absence of NH4Cl were compared to WNV strain NY99-flamingo 382–99
[10] and to WNV recovered from plasmid pFLWNV [42] respectively. Amino acid replacements are shown in bold within parentheses. The presence of nucleotide
substitution A103G was analyzed by nucleotide sequencing on different biological clones from each population subjected to 10 serial passages in the absence of NH4Cl.
Each biological clone corresponded to an individual lysis plaque produced by infection in semisolid agar medium. N.D. Not done.
doi:10.1371/journal.pone.0069479.t003
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single amino acid substitution was sufficient to increase resistance
to acidotropic compounds. In contrast to other flavivirus mutants
with altered acidic pH requirements, which displayed amino acid
substitutions on the external glycoproteins of the virion, E or M
(see Introduction), the amino acid replacement here reported was
located in the core of the virion, which is enveloped by the lipid
bilayer. Considering that the WNV C protein has been proposed
to be a determinant of virulence [51], and that single point
mutations can either enhance [52] or decrease WNV virulence
[53], it is not surprising that when the effect of K3E amino acid
replacement was analyzed in vivo using the murine model, a major
reduction of the infectivity in vivo was noticed. This can be derived
from alterations of functions of basic amino acids inside this region
during the multiple steps of the WNV infectious cycle (see below).
The WNV C protein is a multifunctional protein that can be
found inside infected cells in both the cytoplasm and the nucleus
[54], and has been implicated in multiple aspects of WNV
infectious cycle including viral replication [55], induction of
apoptosis [56], or disruption of epithelial barrier helping to virus
dissemination [57]. Indeed, the interaction of the C protein of
WNV with a growing variety of distinct cellular partners has been
reported. These include Hsp70 [58], Jab1 [54], I2
PP2A [59],
HDM2 [56], importin a/b [60], Sec3 [61], MKRN1 [62], or
DDX56 [63]. The mature WNV C protein (105 amino acids) is
produced by the cleavage of the hydrophobic C-terminus of the
protein [1,64]. The protein forms dimers that associate to form
tetramers, which exhibit highly positively charged surfaces that are
presumed to interact with the negatively charged RNA [64]. In
fact, the presence of positively charged residues within the
disordered regions of both the N and the C-terminus of the
mature C protein has been associated to their ability to interact
with nucleic acids [45,65]. Nucleic acid binding properties of the C
protein are important for RNA packaging in the nucleocapsid, and
the lack of a well-formed protein shell in the nucleocapsid suggests
that the basic C protein functions like a histone [64,66]. In
addition to this, and due to its RNA binding ability, the C protein
promotes viral replication by helping RNA rearrangements and by
contributing to RNA cyclization [45,55]. The amino acid
replacement found on Res virus (K3E) was located at the N-
terminus of the protein, being part of a conserved epitope among
the Japanese encephalitis serocomplex [67], and involved the
change of one basic residue for an acidic one. This change of
electric charge could carry alterations on the C functions involving
RNA binding and/or interactions with cellular partners. Accord-
ing with this hypothesis, comparative genomic analysis of the C
sequences from 486 strains revealed that mutations changing basic
to acidic residues are very infrequent in WNV, and showed that
this position in the WNV C protein was always occupied by a basic
residue. In the case of Dengue virus, the mature C protein has
been involved in virion morphogenesis due to its ability to interact
with lipid droplets through its central hydrophobic residues [68],
and the basic residues of the N-terminus of the C protein have
been proved to be essential for viral particle formation [69].
Agreeing with this data, a role of the WNV C protein during the
assembly of infectious particles has also been recently assessed
[63]. The mutant here described showed an increase on the
release of infectious particles, upon addition of NH4Cl or
concanamycin A, compared to the WT. Interestingly, this
phenomenon was not observed under standard culture conditions,
or upon the addition of an inhibitor of furin-mediated maturation,
suggesting that it takes place only when acidification is inhibited.
Supporting this hypothesis, a similar inhibition of prM cleavage
derived from NH4Cl treatment between WT and mutant viruses
was observed. Results from in vitro furin cleavage of virions
produced in the presence of NH4Cl pointed that acidic pH was
also required for furin-mediated maturation of Res virus as well as
for WT virus, thus, suggesting that, at neutral pH, Res virus does
not undergo structural changes associated to virus maturation that
expose the furin cleavage site.
Exposure of WNV particles to acidic pH in the absence of target
membranes results in a loss of fusion capacity and viral
inactivation [32,44,70,71]. Conversely, flavivirus immature parti-
cles are deficient on membrane fusion and hence more resistant to
acid-inactivation [39,72]. As conformational rearrangements
following acid exposure in solution resemble those induced inside
endosomes that provide the driving force for membrane fusion
[73], acid-inactivation analyses have been proven useful to analyze
conformational rearrangements induced by acidic pH [32,35,44].
In the present report, no differences were observed between WT
and Res WNV produced under normal conditions, suggesting that
fusion pH of mature particles was similar for both viruses.
However when a parallel analysis was carried with the viruses
grown in the presence of NH4Cl (which are enriched in immature
particles), Res WNV was more sensitive to acid-induced inactiva-
tion than WT, pointing to a better fusion competence of these
particles. This phenomenon would constitute an advantage under
conditions of impaired endosome acidification induced by NH4Cl
or concanamycin A, explaining the molecular basis of resistance to
inhibitors of organelle acidification. Indeed, increase in the
sensitivity to acid-induced inactivation or displacement of fusion
pH threshold to less acidic values is a well documented mechanism
that reduces the sensitivity to drugs that impair endosome
acidification [31,74]. These findings are compatible with the
observation that Res virus was able to produce more infectious





p.i.) Nucleotide substitutions found in the consensus sequence
b
C prM M E
N.2.1 102 11 A1853T (Q296L) T2029A
(L355M)
N.4.1 104 7 A208C (I38L) C1302T
N.4.2 104 9 A103G (K3E)
N.4.3 104 10 A103G (K3E) A509G (N15S)
Brain from dead mice was homogenated and used to infect Vero cells. Viral RNA from infected cultures was extracted and amplified by RT-PCR and the nucleotide
sequence of the genomic region encoding the structural proteins was determined. Nucleotide replacements found on the genomic sequence encoding WNV structural
proteins were compared to WNV strain NY99-flamingo 382–99 [10]. Amino acid replacements are shown in bold within parentheses.
doi:10.1371/journal.pone.0069479.t004
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(hence fusion-competent) particles/genomic RNA under condi-
tions of impaired organelle acidification.
Several hypotheses can explain the molecular basis of this
behaviour. For instance, alterations on the nucleocapsid could
induce structural perturbations to the immature particles that
facilitate conformational rearrangements triggered by acidic-pH,
hence increasing their fusion competence and infectivity. Howev-
er, this seems unlikely, since the furin cleavage site, whose
exposure is associated to acid-induced conformational rearrange-
ments associated to viral maturation [14,39], was not exposed in
Res virus grown in the presence of NH4Cl. An alternative non-
excluding hypothesis is that the mutation in the capsid, located
within a region putatively involved in RNA-binding, could lead to
a more unstable virus, therefore, viral particles maybe able to
release the genome more efficiently in the next cycle of infection
even though the virus population consists mainly of immature
virus. In any case, these rearrangements or alterations of the
mechanical properties of the virion should take place without an
increase in prM cleavage, since, at the level of resolution of our
observations, the amount of M in Res particles grown in the
presence of NH4Cl did not appear to be different from that of WT
particles produced under similar conditions. This might imply that
the increase in infectivity was not related to an increase in the
degree of maturation of viral particles. In fact, several studies have
shown that prM is present on infectious virions [17,72,75]. Thus,
as recently reviewed [25], the infectivity of flaviviruses and its
mechanistic is more probably a multifactorial process and,
whereas the proteolytic processing of prM is a necessary step in
the virus life cycle, complete maturation is not required for
infectivity or fusion activity, so partially matured particles,
heterogeneous in residual prM content and in arrangement of E
proteins on the virion, can be infectious under certain conditions.
Consisting with this view, the mutant WNV produced in the
presence of NH4Cl exhibited increased infectivity than WT virus
without showing any noticeable effect on the degree of maturation
of viral particles, specifically in their M content or the need for
acidic pH during in vitro treatment with furin.
Although it is not obvious to explain how a mutation located on
the internal capsid protein can lead to alterations on the fusion-
competence of virions, the interaction between capsid protein and
surface glycoproteins is well documented for the alphaviruses
[76,77,78], which share multiple features with flaviviruses related
to its dependence on pH for membrane fusion [23]. Furthermore,
it has been proposed that acid-induced rearrangements of
alphavirus fusion glycoproteins might also cause a reorganization
of the capsid-binding internal glycoprotein tails altering the
nucleocapsid structure [79], a finding that evidence the crosstalk
between components located in both sides of the viral envelope.
Even more, a detailed analysis of the structure of immature
flavivirus particles reveals that contacts between the nucleocapsid
Figure 8. Location of mutated residues found in viruses recovered frommice infected with Res virus. (A) Structure of WNV pr/E complex
based on cryo-electron microscopy reconstruction [20]. (B) Crystal structure of WNV E glycoprotein [82]. The positions of amino acid replacements
Q296L (light green) and L355M (black) found in the E glycoprotein of virus N.2.1 and amino acid replacement N15S (purple) found in the pr peptide
(orange) of virus N.4.3 are highlighted. Color code for E glycoprotein: DI, red; DII, yellow; DIII, blue; fusion loop, green. (C) Ribbon diagram showing
the location of I38L amino acid substitution found in virus N.4.1 in the structure of the central portion of a dimer of WNV C protein [64]. The two
subunits of the dimer are colored in cyan and blue respectively.
doi:10.1371/journal.pone.0069479.g008
Figure 9. Analysis of the resistance to NH4Cl of viruses recovered from dead mice infected with Res virus. Vero cells were infected (MOI
of 0.5 PFU/cell) in the absence (control) or in the presence of 25 mM NH4Cl with WT, Res, N.2.1, N.4.1 or N.4.3 virus. Amino acid replacements
compared to WT are indicated into brackets for each virus (see also Table 4). Virus titers were determined 24 h.p.i. Dashed line indicates the virus titer
shown by WT in the presence of NH4Cl. Error bars represent SD. The data presented are product of three independent experiments.
doi:10.1371/journal.pone.0069479.g009
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and the lipid bilayer can occur [80], supporting the notion of a
crosstalk between the nucleocapsid and the external protein shell
of the virion that directly interact with the acidic pH of the
environment.
The selection of additional mutations on the structural proteins
of virus isolated from dead mice infected with Res virus also points
to the existence of a genetic connection between the internal C
protein and the external virion proteins prM and E, supporting the
notion of a crosstalk between the capsid protein and the surface
glycoproteins. Indeed, the analysis of the genetic relationships
between WNV proteins has revealed unexpected interactions [81].
When the resistance to NH4Cl of viruses recovered from dead
mice was tested, it was observed that loss of K3E amino acid
replacement was associated to a reduction on the degree of
resistance to NH4Cl. Interestingly, the virus N.4.3 that carried the
amino acid replacement N15S in the prM and conserved the K3E
at the C protein, did not show any noticeable degree of resistance
to NH4Cl. In this way, this replacement counteracted the
advantage conferred by the K3E amino acid replacement on the
C protein of the Res virus. The molecular basis of this
compensatory effect are difficult to explain at this moment,
however it is well known that the prM facilitates the folding and
trafficking of the E protein during virus biogenesis and that
removal of pr peptides from the virion primes the viral particle in
their mature, metastable structural state, ready for the low-pH
triggered fusion [25]. Therefore, changes in this region could have
multiple effects during virus maturation and/or entry. The N15S
replacement is located at the conserved N-linked glycosylation site
of the prM [49], thus probably altering its glycosylation. The
impairment of the glycosylation of this protein by introduction of
the N15Q amino acid replacement has been shown to reduce
secretion of WNV particles, although with modest effect on their
infectivity, and thus, it has been hypothesized that the glycosyl-
ation of the prM assists protein folding at the endoplasmic
reticulum rather than virus infection [49].
Assessment of whether an amino acid replacement on the virion
core, surrounded by a lipid envelope, can contribute to evasion
from acidotropic drugs, whose effect is supposed to target the
external virion proteins, which are accessible to pH variations, is
not an easy task. In this way, the genetic connection between the
mechanisms of escape reported for this mutant and its relationship
with acidic pH organelles invites to revisit the role of the C protein
during entry and assembly of WNV and other related flaviviruses.
Supporting Information
Figure S1 Prediction of disordered and hydrophobic
regions of the WNV C protein. (A) Disorder disposition of the
amino acid residues of the WNV C protein strain NY99-flamingo
382–99 was calculated with the meta-predictor PONDR-FITTM
[83]. (B) Prediction of hydrophobic regions of the WNV C protein
performed with TMHMM [84]. White arrow points to the
position mutated that increased resistance to NH4Cl. Black
arrowhead indicates the site of maturation cleavage [64].
(TIF)
Figure S2 Multiple sequence alignment of the flavivirus
C proteins.Multiple alignment was performed with T-COFFEE
[85]. GenBank accessions: WNV (AF196835.2), JEV, Japanese
encephalitis virus (NC_001437.1); MVEV, Murray Valley en-
cephalitis virus (NC_000943.1); USUV, Usutu virus
(NC_006551.1); SLEV, St. Louis encephalitis virus
(AEN02430.1); DENV, Dengue virus (ACF49259.1,
ACW82869.1); YFV, Yellow Fever virus (ACN41908.1). Basic
and acid residues are highlighted. White arrow points to the
position mutated that increased resistance to NH4Cl. Black
arrowhead indicates the site of maturation cleavage [64].
(TIF)
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